Stenger Family Office LLC Invests $4.93 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Stenger Family Office LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 9,749 shares of the healthcare conglomerate’s stock, valued at approximately $4,932,000. UnitedHealth Group comprises approximately 1.7% of Stenger Family Office LLC’s holdings, making the stock its 16th biggest holding.

A number of other institutional investors and hedge funds have also bought and sold shares of UNH. Lifelong Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $317,000. Acorns Advisers LLC raised its stake in shares of UnitedHealth Group by 31.5% in the 4th quarter. Acorns Advisers LLC now owns 468 shares of the healthcare conglomerate’s stock valued at $237,000 after buying an additional 112 shares in the last quarter. Operose Advisors LLC boosted its position in shares of UnitedHealth Group by 39.7% during the 4th quarter. Operose Advisors LLC now owns 1,573 shares of the healthcare conglomerate’s stock valued at $796,000 after acquiring an additional 447 shares in the last quarter. United Capital Financial Advisors LLC raised its position in UnitedHealth Group by 0.6% in the fourth quarter. United Capital Financial Advisors LLC now owns 73,746 shares of the healthcare conglomerate’s stock worth $37,305,000 after purchasing an additional 447 shares in the last quarter. Finally, GABELLI & Co INVESTMENT ADVISERS INC. acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $253,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $583.43 on Wednesday. The stock has a market cap of $533.67 billion, a P/E ratio of 37.64, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The stock’s 50-day moving average price is $514.87 and its two-hundred day moving average price is $542.12. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $438.50 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $5.83 earnings per share. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.44%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Analyst Upgrades and Downgrades

Several analysts recently commented on UNH shares. Barclays decreased their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Truist Financial upped their price objective on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a “buy” rating in a research note on Friday, April 11th. Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Finally, Mizuho boosted their price objective on UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th. Twenty-one analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $632.85.

Insider Activity

In related news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.